Cangen Biotechnologies Inc. And Dai Nippon Printing Co., Ltd. Move Forward With Development Of An Early Stage Lung Cancer Diagnostic
Cangen Biotechnologies, Inc. and Dai Nippon Printing Co., Ltd. (DNP) of Japan are pleased to announce that they will move forward with a clinical trial phase of an early stage lung cancer diagnostic.
(more...)
(more...)